Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2007
11/29/2007WO2007135105A1 Means and method for inducing exon-skipping
11/29/2007WO2007134460A1 Pancreatic b-cells expressing abca1 and uses thereof
11/29/2007WO2007089584A3 Compositions and their uses directed to huntingtin
11/29/2007WO2007059030A3 Llo-encoding dna/nucleic acid vaccines and methods comprising same
11/29/2007WO2007047482A3 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics
11/29/2007WO2007045511A3 Deregulated genes and/or processes in inflammatory arthritis
11/29/2007WO2006053130A3 Composition and method for clusterin-mediated stem cell therapy for treatment of atherosclerosis and heart failure
11/29/2007WO2004037202A3 Gb virus c and methods of treating viral infections
11/29/2007WO2004015086A3 Enhancement of adenoviral oncolytic activity in prostate cells by modification of the e1a gene product
11/29/2007US20070276128 Stabilized Proteins with Engineered Disulfide Bonds
11/29/2007US20070275926 Treatment of disorders of the peripheral nervous system
11/29/2007US20070275925 Asthma diagnosis and therapy
11/29/2007US20070275924 Synthetic Lipid Rafts and Methods of Use
11/29/2007US20070275920 Method for Chromatographic Separation of a Nucleic Acid Mixture
11/29/2007US20070275917 Rna Capable of Suppressing Expression of Klf5 Gene
11/29/2007US20070275916 Methods of Identifying Compounds Which Modulate Granulocite-Colony Stimulating Factor (G-Csf) Dependent Processes by Modulation of the Levels of Suppressor of Cytokine Signaling (Socs)
11/29/2007US20070275915 Tmprss2 Regulatory Sequences and Uses Thereof
11/29/2007US20070275914 Therapeutic Compositions
11/29/2007US20070275895 Inhibiting proliferation of immune cells in leukemia comprising administering an antibody that specifically binds a follistatin-3 polypeptide; inhibiting B cell or T cell proliferation
11/29/2007US20070275891 OBG3 globular head and uses thereof
11/29/2007US20070275873 Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting
11/29/2007US20070275441 Ocular Tissue Modification
11/29/2007US20070275440 Regulation of transcription factor, nf-il6/lap
11/29/2007US20070275401 USE OF Mx GTPASES IN THE PROGNOSIS AND TREATMENT OF CANCER
11/29/2007US20070275391 Novel g-protein coupled receptors and dna sequences thereof
11/29/2007US20070275099 MST1 modulation of apoptosis in cardiac tissue and modulators of MST1 for treatment and prevention of cardiac disease
11/29/2007US20070275071 Use of Microparticles for Antigen Delivery
11/29/2007US20070275069 Hydrophobic biomolecular structure
11/29/2007US20070275047 Oligonucleotides Related to Lipid Membrane Attachments
11/29/2007US20070275029 Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders
11/29/2007US20070275018 Relates to gene NcSAG4, the RNA messenger of said gene, the oligonucleotides designed based on the nucleotide sequence thereof, and to protein NcSAG4 encoded thereby, and expression vectors, for the purpose of diagnosis and vaccination for the prevention of neosporosis
11/29/2007US20070275003 polynucleotides that code for HPV E6/E7 fusion proteins, having mutagenesis points, used to generate immune responses against HPV and prevent or treat cervical cancer
11/29/2007US20070274994 Virulence-Associated Adhesins
11/29/2007US20070274989 Methods and Compositions for the Prevention and Treatment of Sepsis
11/29/2007US20070274973 Method of controlling fungal pathogens, and agents useful for same
11/29/2007US20070274970 Stem Cells
11/29/2007US20070274969 Immortalization of Mammalian Cells
11/29/2007US20070274958 Postnatal Stem Cells and Uses Thereof
11/29/2007US20070274957 Compounds are substantially uncharged morpholino oligonucleotides having a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5'-terminal regions of the viral RNA
11/29/2007US20070274953 Photochemical internalization for delivery of molecules into the cytosol
11/29/2007US20070274952 Compositions and Methods for Modifying the Content of Polyunsaturated Fatty Acids in Biological Cells
11/29/2007US20070274949 Cd25 Dna Vaccines for Treating and Preventing T-Cell Mediated Diseases
11/29/2007US20070274946 Tolerance to Graft Prior to Thymic Reactivation
11/29/2007US20070274908 Methods and compositions related to adenoassociated virus-phage particles
11/29/2007CA2652689A1 Method of constructing gene transport support
11/29/2007CA2652530A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
11/29/2007CA2652408A1 Means and method for inducing exon-skipping
11/29/2007CA2652365A1 Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
11/28/2007EP1860192A1 Compositions and methods for treating intracellular diseases
11/28/2007EP1860189A1 Human gene
11/28/2007EP1860188A2 Human cytokine receptor
11/28/2007EP1860115A1 Oligonucleotide derivative, probe for detection of gene, and dna chip
11/28/2007EP1859813A1 Remedy for disease associated with apoptotic degeneration in ocular cell tissue with the use of siv-pedf vector
11/28/2007EP1859812A1 Polycation chargeable polymer and use as carrier of nucleic acid
11/28/2007EP1859808A1 Novel sugar uptake activator and method for screening the same
11/28/2007EP1859804A1 Anticancer agent to be combined with telomelysin
11/28/2007EP1859792A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules
11/28/2007EP1858558A2 Nod1 as an anti-tumor agent
11/28/2007EP1858547A1 Immunogenic compositions
11/28/2007EP1858332A2 Lentiviral vectors and their use
11/28/2007EP1713511A4 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
11/28/2007EP1691844A4 Methods and compositions for treatment of interferon-resistant tumors
11/28/2007EP1412486B1 Method for virus propagation
11/28/2007EP1115863B1 Ucp4
11/28/2007EP1084260B1 Caspase-9 deficient animals and the use thereof
11/28/2007EP0910387B1 Apoptosis associated protein bbk
11/28/2007CN200980747Y Medicine releasing structure for medicine eluting apparatus
11/28/2007CN101080499A Genomic screen for epigenetically silenced tumor suppressor genes
11/28/2007CN101078012A 干细胞分化 Stem cell differentiation
11/28/2007CN100351385C Herpes viruses for immune modulation
11/28/2007CN100351376C RNA interfered target sequence of HBV and use thereof
11/28/2007CN100350979C Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
11/28/2007CN100350970C 因子 Factor
11/27/2007US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007US7300790 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
11/27/2007US7300765 SC6 for diagnosis of cancers
11/27/2007US7300749 Molecules of the pyrin domain protein family and uses thereof
11/27/2007US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007US7300658 For use in vaccines
11/27/2007CA2340728C Methods of treating hypertension and compositions for use therein
11/22/2007WO2007134288A2 Electrode-battery assembly for tens device
11/22/2007WO2007134132A2 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
11/22/2007WO2007133990A2 System and method for selective review of event data
11/22/2007WO2007133970A2 Estimation of speed and direction of travel in a wlan positioning system
11/22/2007WO2007133967A2 Estimation of position using wlan access radio propagation characteristics in a wlan positioning system
11/22/2007WO2007133959A2 Device for treating chronic total occlusion
11/22/2007WO2007133955A2 Flexible and extendable drill bit assembly
11/22/2007WO2007133918A2 Enhancement of visual perception iii
11/22/2007WO2007133771A2 Multipurpose adiabatic potable water production apparatus and methods
11/22/2007WO2007133730A2 Materials and methods for control of infections
11/22/2007WO2007133674A2 Lentiviral vector compositions, methods and applications
11/22/2007WO2007132947A1 Bcl-xL TRANSGENIC ANIMAL AND UTILIZATION OF THE SAME
11/22/2007WO2007132891A1 Method of transferring substance into cell
11/22/2007WO2007132873A1 Freeze-dried product for transferring nucleic acid, oligonucleic acid or derivative thereof
11/22/2007WO2007132867A1 Prophylactic and therapeutic agent for cancer
11/22/2007WO2007132096A2 System for transposing hyperactive recombinant derivatives of mos-1 transposon
11/22/2007WO2007132012A1 Method for isolating homogeneous populations of transduced progenitors stably expressing specific levels of a transgene
11/22/2007WO2007070856A3 Method for treating immune dysfunction by regulation of cd40 ligand expression
11/22/2007WO2006128044A3 Compositions and methods for altering cellular functions
11/22/2007WO2005115479A3 Peptide conjugated, inosine-substituted antisense oligomer compound and method
1 ... 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 ... 870